Intuitive Surgical, Inc. Website

Intuitive Surgical, Inc.

NasdaqGS-ISRG

Basic

  • Market Cap

    $155.2B

  • EV

    $150.53B

  • Shares Out

    355.35M

  • Revenue

    $7,572.5M

  • Employees

    13,676

Margins

  • Gross

    66.86%

  • EBITDA

    31.51%

  • Operating

    25.79%

  • Pre-Tax

    29.46%

  • Net

    27.65%

  • FCF

    5.54%

Returns (5Yr Avg)

  • ROA

    12.46%

  • ROTA

    14.46%

  • ROE

    14.32%

  • ROCE

    14.4%

  • ROIC

    19.76%

Valuation (TTM)

  • P/E

    —

  • P/B

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

  • EV/Gross Profit

    —

Valuation (NTM)

  • Price Target

    $467.53

  • P/E

    —

  • PEG

    —

  • EV/Sales

    —

  • EV/EBITDA

    —

  • P/FCF

    —

Financial Health

  • Cash

    $4,757.2M

  • Net Debt

    -$4,757.2M

  • Debt/Equity

    0.01

  • EBIT/Interest

    —

Growth (CAGR)

  • Rev 3Yr

    13.62%

  • Rev 5Yr

    13.39%

  • Rev 10Yr

    14.06%

  • Dil EPS 3Yr

    9.24%

  • Dil EPS 5Yr

    11.5%

  • Dil EPS 10Yr

    15.71%

  • Rev Fwd 2Yr

    14.74%

  • EBITDA Fwd 2Yr

    17.14%

  • EPS Fwd 2Yr

    15.38%

  • EPS LT Growth Est

    17.8%

Dividends

  • Yield

    —

  • Payout

    —

  • DPS

    —

  • DPS Growth 3Yr

    —

  • DPS Growth 5Yr

    —

  • DPS Growth 10Yr

    —

  • DPS Growth Fwd 2Yr

    —

Select a metric from the list below to chart it

Dec '14

Dec '15

Dec '16

Dec '17

Dec '18

Dec '19

Dec '20

Dec '21

Dec '22

Dec '23

LTM

Dec '24 (E)

Dec '25 (E)

Dec '26 (E)

Metric
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
LTM

Total Revenues

4,478.5

4,358.4

5,710.1

6,222.2

7,124.1

7,572.5

Total Revenues % Chg.

20.3%

-2.7%

31%

9%

14.5%

13.6%

Cost of Goods Sold, Total

1,368.3

1,497.2

1,751.6

2,026.2

2,394.6

2,509.8

Gross Profit

3,110.2

2,861.2

3,958.5

4,196

4,729.5

5,062.7

Selling General & Admin Expenses, Total

1,178.4

1,216.3

1,466.5

1,711.8

1,963.9

2,035.9

R&D Expenses

557.3

595.1

671

879

998.8

1,074.1

Other Operating Expenses, Total

1,735.7

1,811.4

2,137.5

2,590.8

2,962.7

3,110

Operating Income

1,374.5

1,049.8

1,821

1,605.2

1,766.8

1,952.7

Interest And Investment Income

116.8

103.5

80.8

106

203.1

267

Net Interest Expenses

116.8

103.5

80.8

106

203.1

267

Currency Exchange Gains (Loss)

4.9

-1.4

-0.9

-27.3

-3.7

15

EBT, Excl. Unusual Items

1,496.2

1,151.9

1,900.9

1,683.9

1,966.2

2,234.7

Gain (Loss) On Sale Of Investments

—

—

6

55.1

-10.6

-49

-7.3

-3.8

Legal Settlements

—

—

—

—

-28.1

—

—

EBT, Incl. Unusual Items

1,502.2

1,207

1,890.3

1,606.8

1,958.9

2,230.9

Income Tax Expense

120.4

140.2

162.2

262.4

141.6

121.5

Earnings From Continuing Operations

1,381.8

1,066.8

1,728.1

1,344.4

1,817.3

2,109.4

Minority Interest

—

—

—

—

-2.5

-6.2

-23.5

-22.1

-19.3

-15.7

Net Income

1,379.3

1,060.6

1,704.6

1,322.3

1,798

2,093.7

Net Income to Common Incl Extra Items

1,379.3

1,060.6

1,704.6

1,322.3

1,798

2,093.7

Net Income to Common Excl. Extra Items

1,379.3

1,060.6

1,704.6

1,322.3

1,798

2,093.7

Total Shares Outstanding

348

353.1

357.7

350

352.3

355.3

Weighted Avg. Shares Outstanding

346.2

351.1

356.1

355.7

351.2

353

Weighted Avg. Shares Outstanding Dil

358.4

361

365.8

362

357.4

359.5

EPS

4

3

4.8

3.7

5.1

5.9

EPS Diluted

3.9

2.9

4.7

3.7

5

5.8

EBITDA

1,574.5

1,320.6

2,128.4

1,959

2,169

2,386

Effective Tax Rate

8%

11.6%

8.6%

16.3%

7.2%

5.4%